Literature DB >> 11685118

Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

S C Hoffmann1, E M Stanley, E Darrin Cox, N Craighead, B S DiMercurio, D E Koziol, D M Harlan, A D Kirk, P J Blair.   

Abstract

BACKGROUND: Genetic variations in cytokine genes are thought to regulate cytokine protein production. However, studies using T cell mitogens have not always demonstrated a significant relationship between cytokine polymorphisms and in vitro protein production. Furthermore, the functional consequence of a polymorphism at position -330 in the IL-2 gene has not been described. We associated in vitro protein production with cytokine gene polymorphic genotypes after costimulation of cultured peripheral blood lymphocytes.
METHODS: PBL were isolated from forty healthy volunteers. Cytokine protein production was assessed by enzyme-linked immunosorbent assay. Polymorphisms in interleukin- (IL) 2, IL-6, IL-10, tumor necrosis factor (TNF-alpha), tumor growth factor (TGF-beta), and interferon (IFN-gamma) were determined by polymerase chain reaction (PCR).
RESULTS: Statistical difference between protein production and cytokine polymorphic variants in the IL-10, IFN-gamma, and TNF-alpha genes was not evident after 48-hour stimulation with concanavalin-A. In contrast, after anti-CD3/CD28 stimulation significant differences (P<0.05) were found among high and low producers for IL-2, IL-6, and among high, intermediate, and low producers for IFN-gamma, and IL-10. Augmented levels of IL-2 in individuals that were homozygous for the polymorphic IL-2 allele were due to an early and sustained enhancement of IL-2 production. No association was found among TNF-alpha and TGF-beta genotypes and protein production.
CONCLUSION: Polymorphisms in IL-2, IL-6, IL-10, and IFN-gamma genes are associated with their protein production after anti-CD3/CD28 stimulation. The profound effect of the IL-2 gene polymorphism in homozygous individuals may serve as a marker for those that could mount the most vigorous allo- or autoimmune responses, or perhaps become tolerant more easily.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685118     DOI: 10.1097/00007890-200110270-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  74 in total

1.  The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.

Authors:  Kui Zhang; Lushun Zhang; Xianmin Wang; Lin Zhang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome.

Authors:  Elham Barkhordari; Nima Rezaei; Mahdi Mahmoudi; Pegah Larki; Hamid Reza Ahmadi-Ashtiani; Bita Ansaripour; Maryam Alighardashi; Mohammad Bashashati; Ali Akbar Amirzargar; Naser Ebrahimi-Daryani
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

3.  Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.

Authors:  James R Cerhan; Sophia Wang; Matthew J Maurer; Stephen M Ansell; Susan M Geyer; Wendy Cozen; Lindsay M Morton; Scott Davis; Richard K Severson; Nathaniel Rothman; Charles F Lynch; Sholom Wacholder; Stephen J Chanock; Thomas M Habermann; Patricia Hartge
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

4.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.

Authors:  Rama Devi Mittal; Parmeet Kaur Manchanda
Journal:  Immunogenetics       Date:  2007-01-04       Impact factor: 2.846

Review 5.  Molecular epidemiology, cancer-related symptoms, and cytokines pathway.

Authors:  Cielito C Reyes-Gibby; Xifeng Wu; Margaret Spitz; Razelle Kurzrock; Michael Fisch; Eduardo Bruera; Sanjay Shete
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

Review 6.  Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II.

Authors:  Caroline Monchaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 7.  Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.

Authors:  Caroline Monchaud; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Postmortem cytokine levels and severity of traumatic injuries.

Authors:  Sohtaro Mimasaka; Yuki Ohtsu; Shigeyuki Tsunenari; Masato Funayama
Journal:  Int J Legal Med       Date:  2006-04-04       Impact factor: 2.686

9.  Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

Authors:  N Rezaei; A A Amirzargar; Y Shakiba; M Mahmoudi; B Moradi; A Aghamohammadi
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 10.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.